Drugs and Pharmaceuticals

376 articles:
by Hanan Hammad

Needle phobic? Nasal spray flu vaccine allays fear but has limited access in Canada

Canadians who avoid the flu shot because they fear needles have an alternative that won’t make them hold their breath until it’s over. But availability may pose a problem for access.

by Muneeb Ahmed

Three tools clinicians use to debunk viral health myths

Canadians face a steady stream of confident health claims; some partly right, others wrong and risky – and some potentially fatal. Health care experts share some best practices to combat myths in clinic.

by Callia Georgoulis

Barbie has an insulin pump and CGM too: Why representation in chronic illness education matters

I never had a Barbie with dark hair, brown eyes and an insulin pump when I was growing up. But today’s girls can. And that is progress worth celebrating.

by Jackie Tsang Susan Dong

Tylenol misinformation puts pregnant patients at risk

Casting doubt on Tylenol without solid evidence does not empower pregnant people, it corners them. It adds guilt, stigma and undermines their confidence in making safe decisions for themselves and their babies.

by Alex Hoagland

Empowering pharmacists is about more than saving emergency departments – it’s about equity in health care

Not only did Ontario's move to allow pharmacists to prescribe for certain minor ailments reduce ED strain, but it also reduced inequities in access to care.

by Geoffrey M. Pradella

Expanding access to disability supports: the case for impact investing

Thanks to limited access to interventions and income thresholds that fail to account for the cost of caregiving, families with children with neurodevelopmental disabilities are often left to pay out-of-pocket for services.

by Linxi Mytkolli

Trust those who heal, not those who provoke

A Seuss-style rhyme on the very real harm of health misinformation.

by Abigail Jaimes Zelaya

Black mistrust is logical and rational: What public health policymakers must learn from Black communities

Black communities are not hesitant just for the sake of it. They are hesitant because of memory. They need structural change built from trust, not just crisis.

by Matthew Cho

When patients ask about psychedelics

Over the past decade, scientific interest in psychedelics such as psilocybin and MDMA has risen, along with recreational use. This has put physicians in a difficult place – one our medical training has not prepared us for.

by AnnMarie Churchill Marion Cooper

Rethinking mental health and substance use health solutions

What if you or someone you know needs mental health and substance use health care right now? Do you know exactly where to go to get what you need?

by Tushar Sood

‘And the dead cannot recover’: The fatal consequences of closing Supervised Consumption Sites

Bill 223 ordered the closure of more than half of Ontario’s 17 supervised consumption sites with no equivalent replacement. For many medical students like me, this is personal.

by Charissa Egger

The MS treatment gap: How costs and outdated policies limit care in Canada

Early, aggressive treatment can significantly improve outcomes for people living with MS. But provinces have yet to implement coverage policies that would ensure patients receive optimal care.

by Homira Osman Stacey Lintern Danielle Campo McLeod

Approved but denied: Canadians with neuromuscular diseases face unequal access to treatment

We are told health care in Canada is equal for everyone. But it is not. Particularly for patients with neuromuscular diseases, what you get depends on where you live.

by Nilah Ahimsadasan

When care doesn’t translate

For South Asian communities, improved care means earlier screening, culturally relevant guidance and meaningful language access. Without these changes, we risk continuing a pattern of preventable harm.

by Lisa Dolovich

Better together: Where are the pharmacists in Ontario’s primary care plan?

We have said it before. We will say it again. Pharmacists in Ontario are well-prepared for an expanded role in our health-care system.

by James Dickinson

It’s not just the measles . . .

Many have forgotten how serious infections from Measules, Mumps, Rubella and Varicella can be because we have not seen them for many years. I am reminded every day by my mumps-induced deafness.

by Laurie Proulx

Breathing for both of us

I walked into the obstetrics unit – 36 weeks pregnant, out of breath and scared. I had been here before, but this time was different.

by Kevin Zhao

DEI dying: Why sex/gender in health research should matter to us all

As the U.S. disengages with sex differences research, Canada must double down on its own research program. Science takes years to bear fruit – the research we invest in today are the therapies we have tomorrow.

by Timothy Caulfield

Vaccine safety, politics and the nocebo effect

The nocebo effect has an important role to play in vaccine uptake and safety. We must vigorously counter the misinformation and political spin that helps to fuel the accelerating vaccine concern vortex.

by Indu Subramanian

Decades after it was declared eliminated, I fear the heartbreaking, avoidable consequences of measles

Fatal encephalitis from measles technically and biologically could be abolished as a human disease. Yet, I fear the downstream consequences of what the anti-vaccine movement could bring.

1 of 19